Image-guided therapy firm Brainlab and Mitsubishi Heavy Industries are teaming up to launch their Vero stereotactic body radiation therapy (SBRT) system at this week's American Society for Radiation Oncology (ASTRO) annual meeting in San Diego.
Vero SBRT combines intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and real-time tumor tracking into one treatment delivery system. It features the ability to dynamically contour the treatment beam to address the tumor from every angle as the machine moves around the patient, according to Brainlab of Munich and Mitsubishi of Tokyo.
Clinicians can also move the treatment beam, dynamically and in real-time, to better treat lung and liver tumors, the companies said.
Related Reading
BrainLab adds IGRT monitoring, July 26, 2010
Varian, BrainLab expand partnership, June 30, 2010
Elekta, Mitsubishi report treatment milestone, May 17, 2010
GE inks deal with BrainLab, March 18, 2010
BrainLab scores VectorVision flex install, December 10, 2009
Copyright © 2010 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
